NCT03274687 2026-03-16
Hypofractionated Radiation Therapy or Conventional Radiation Therapy After Surgery in Treating Patients With Prostate Cancer
NRG Oncology
Phase 3 Completed
Clinical Trials
23 trialsNCT00809991 2026-02-18
Hypofractionated Adaptive Image-Guided Radiation Therapy for Localized Adenocarcinoma of the Prostate
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT03345420 2025-12-30
NOVEMBER
University of Utah
Phase 2 Completed
NCT03624478 2025-11-26
Hypofractionated Radiation Therapy in Treating Participants With Breast Cancer Before Surgery
Mayo Clinic
Phase 2 Completed
NCT03570827 2025-09-03
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical Prostatectomy
Mayo Clinic
Phase 2 Completed
NCT00983307 2025-04-30
A Study of Erlotinib Plus Radiotherapy (RT) for Patients With Advanced or Inoperable Non-Small-Cell Lung Cancer
Thomas Jefferson University
Phase 2 Completed
NCT04398095 2025-04-30
HOT
Maria Sklodowska-Curie National Research Institute of Oncology
Phase NA Completed
NCT03035890 2025-04-01
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
West Virginia University
Phase NA Completed
NCT02819843 2025-01-29
A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT03280719 2024-09-19
PRO-SURF
University Hospital, Ghent
Phase NA Completed
NCT04951063 2023-12-15
Fraction Dose Escalation of Hypo-fractionated Radiotherapy in LANSCLC
Sun Yat-sen University
Phase 1 Completed
NCT02311049 2022-12-29
Hypofractionated Radiotherapy for Prostate Cancer
University Hospital, Ghent
Phase 2 Completed
NCT01921803 2022-12-22
Hypofraction
University Hospital, Ghent
Phase 2 Completed
NCT03511781 2021-12-17
HYPORT
Tata Medical Center
Phase NA Completed
NCT02701400 2021-06-22
Tremelimumab and Durvalumab With or Without Radiation Therapy in Patients With Relapsed Small Cell Lung Cancer
Emory University
Phase 2 Completed
NCT02319239 2020-10-28
ESKO
Tampere University Hospital
Phase NA Completed
NCT02383212 2020-01-27
Study of REGN2810 (Anti-PD-1) in Patients With Advanced Malignancies
Regeneron Pharmaceuticals
Phase 1 Completed
NCT01146340 2019-10-04
PHART6
Sunnybrook Health Sciences Centre
Phase 1/2 Completed
NCT02463994 2019-02-08
A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLC
University of Michigan Rogel Cancer Center
Phase EARLY_PHASE1 Completed
NCT00793962 2018-10-11
A Phase â…¢ Randomized Clinical Trial of Postmastectomy Hypofractionation Radiotherapy in High-risk Breast Cancer
ChineseAMS
Phase 3 Completed
NCT03082846 2017-03-21
Treatment of High-grade Gliomas Using Hypofractionated Radiation Therapy -a Phase I Clinical Trial
The Second Hospital of Hebei Medical University
Phase NA Completed
NCT02460744 2015-06-02
2-weeks of Adjuvant Radiotherapy in Patients With Breast Cancer
PIMERIndia
Phase 2 Completed
NCT00129025 2011-10-10
Hypofractionated Radiotherapy (55 Gy/16 Fractions/4 Weeks) for Localized Prostate Cancer
AHS Cancer Control Alberta
Phase 1/2 Completed